G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2001
11/01/2001	WO2001081920A2 Comparative phenotype analysis for assessment of biologically active compounds
11/01/2001	WO2001081919A2 Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose
11/01/2001	WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a
11/01/2001	WO2001081917A2 Chemical signal enhancement of dynamic intensity-based intracellular protein- and fluorophore-based redistribution assays for drug screening
11/01/2001	WO2001081916A2 Methods of evaluating transplant rejection
11/01/2001	WO2001081915A1 Device and process for lateral flow saliva testing
11/01/2001	WO2001081914A1 Reservoir monitoring
11/01/2001	WO2001081911A1 Gas sensor assembly and method
11/01/2001	WO2001081908A1 Field effect transistor device for ultra-fast nucleic acid sequencing
11/01/2001	WO2001081900A1 Gas cell adapted for carbon dioxide
11/01/2001	WO2001081896A1 An ultra-fast nucleic acid sequencing device and a method for making and using the same
11/01/2001	WO2001081890A2 Hydrogel biosensor and biosensor-based health alarm system
11/01/2001	WO2001081632A1 Methods for monitoring the expression of alternatively spliced genes
11/01/2001	WO2001081631A1 Detection of nucleotide sequence variations via the proofreading activity of polymerases
11/01/2001	WO2001081627A2 N-silico-screening for docking on sub-domain iiid of hcv-ires
11/01/2001	WO2001081626A2 Methods for clinical diagnosis
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081615A1 Composition and method for detecting and early and differentiated counting of gram-negative microorganisms
11/01/2001	WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081575A1 Primer for diagnosis of one or more kinds of cancer
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081546A2 CeSERT GENES, PROTEINS, AND MODULATORY COMPOUNDS
11/01/2001	WO2001081544A2 Identification and uses of a hyaluronan receptor
11/01/2001	WO2001081541A2 Pcr-hybridization assays specific for integrated retroviruses
11/01/2001	WO2001081523A1 Yarn strength enhancing agents and compositions and methods employing same
11/01/2001	WO2001081446A1 Electroactive complex, electroactive probe and preparation method
11/01/2001	WO2001081425A1 Use of a secondary cell wall polymer of procaryotic microorganisms
11/01/2001	WO2001081422A1 Secretory tyrosine phosphatases from mycobacteria
11/01/2001	WO2001081418A1 New neuromedin u receptor nmur2 and nucleotides encoding it
11/01/2001	WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	WO2001081409A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081400A1 Nk-2 homeobox transcription factor
11/01/2001	WO2001081375A2 Dna & protein binding miniature proteins
11/01/2001	WO2001081369A2 Peptide potentiation of acid-sensory ion channel in pain
11/01/2001	WO2001081351A1 Fluorescent compounds
11/01/2001	WO2001081002A1 Method and apparatus for making density gradients
11/01/2001	WO2001080998A1 Biphasic reaction vessel and methods of use
11/01/2001	WO2001080965A1 Mipc column cleaning system and process
11/01/2001	WO2001080904A2 Means for diagnosing and treating carcinomas
11/01/2001	WO2001080890A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/01/2001	WO2001080876A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080735A1 Method and device for determining the partial pressure of a gas component in the expiration air of a patient, resolved per respiration
11/01/2001	WO2001080722A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080720A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080719A2 Methods and composition for the diagnosis of schizophrenia
11/01/2001	WO2001080718A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080717A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080716A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080715A2 Methods for identifying compounds useful for preventing acute clinical vascular events in a subject
11/01/2001	WO2001080712A2 Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease
11/01/2001	WO2001080711A2 Method of evaluating a risk of a subject of developing vascular complications
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001	WO2001080622A2 Apparatus and methods for assays of one or more analytes
11/01/2001	WO2001044779A3 Method of processing and testing powdered samples using immunochromatographic strip tests
11/01/2001	WO2001036976A3 Novel diagnosis and treatment for atherosclerosis
11/01/2001	WO2001036939A3 Method for the automatic analysis of microscope images
11/01/2001	WO2001036908A3 Shaft in dissolution testing vessel location monitor
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001035986A3 Methods and compositions for modulating er-stress-induced cholesterol accumulation
11/01/2001	WO2001035067A3 Method and device for determining the threshold of heavy fraction deposit contained in a liquid hydrocarbon fluid
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001034634A8 Tumor suppressor molecules and methods of use
11/01/2001	WO2001031335A3 Cell proliferation diagnosis and screening for modulators
11/01/2001	WO2001028500A3 Uses of antileukoprotease in carcinoma
11/01/2001	WO2001021791A3 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides
11/01/2001	WO2001016374A3 Methods and reagents for in situ amplification
11/01/2001	WO2001011347A3 Humidity sensor
11/01/2001	WO2000062931A9 The use of microfluidic systems in the electrochemical detection of target analytes
11/01/2001	WO2000047775A9 Selection of proteins using rna-protein fusions
11/01/2001	WO2000047764A3 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
11/01/2001	WO2000046600A3 Method of detecting analytes in a sample and support for this purpose
11/01/2001	WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
11/01/2001	WO2000039342A9 Use of essential saccharomyces genes and polypeptides
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000032632A9 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010037182 On-site agricultural product analysis system and method of analyzing
11/01/2001	US20010037099 System for determining analyte concentrations in body fluids
11/01/2001	US20010037078 Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species
11/01/2001	US20010037072 Cassette and applicator for biological and chemical sample collection
11/01/2001	US20010037070 Personal computer breath analyzer for health-related behavior modification and method
11/01/2001	US20010036955 Method of inhibiting angiogenesis
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036807 Method and apparatus for removing fat from meat cuts
11/01/2001	US20010036674 Receiver of sample
11/01/2001	US20010036673 Metal complex; applying a potential to electrode; calibration
11/01/2001	US20010036671 Analyzing the free radsical scavenging of food using a dye and optical fiber detector
11/01/2001	US20010036669 Microfluidic devices and methods
11/01/2001	US20010036668 Biological Particle sorter
11/01/2001	US20010036667 Reservoir monitoring

1 ... 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 ... 3937